wada semaglutide It's the elephant in the jockeys' room. Is it time banned Ozempic? Critics debate banning GLP-1 weight-loss

Remember, titration is key to reducing potential gastrointestinal side effects and enhancing tolerability

2 Many cell types express GLP-1Rs, including cells in the pancreas, digestive tract, heart and skeletal muscle, liver, central nervous system, and immune system, prompting multisystem interest among researchers studying GLP-1R agonists

These trials have targeted various groups, including individuals with diabetes, focusing on cognitive effects, and those with or at risk of AD or PD (summarized in Table 2 for AD and Table 3 for PD)

doi:10.3390/ijms241310449

Novel insights into the pathogenesis of inflammatory bowel diseases